Eur Rev Med Pharmacol Sci 2022; 26 (8): 2875-2890
DOI: 10.26355/eurrev_202204_28619

Radiological assessment of peritoneal carcinomatosis: a primer for resident

V. Granata, R. Fusco, S. Venanzio Setola, C. Sassaroli, S. De Franciscis, P. Delrio, G. Danti, G. Grazzini, L. Faggioni, M. Gabelloni, A. Ottaiano, S. Greggi, R. Patrone, R. Palaia, A. Petrillo, F. Izzo

Division of Radiology, “Istituto Nazionale Tumori IRCCS Fondazione Pascale – IRCCS di Napoli”, Naples, Italy. v.granata@istitutotumori.na.it


The imaging has critical responsibility in the assessment of peritoneal lesions along with estimating the overall extent. Valuing disease burden is crucial for selection of combining cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemotherapy (HIPEC) treatment. An approach that combines the strength of several imaging tools and increases diagnostic accuracy, should be chosen, even if the preferred imaging tool in patients with suspected Peritoneal Carcinomatosis (PC) is CT.

The outcomes of PC are mainly correlated to tumor spread, localization, and lesion size. Accurate assessment of these features is critical for prognosis and treatment planning. These data can be evaluated by Peritoneal Cancer Index (PCI), a quantitative index suggested by Harman and Sugarbaker. Additionally, precise predictive biomarkers should be established to predict PC in patients at risk. The radiomics analysis could predict PC throughout the evaluation of cancers heterogeneity.

Free PDF Download

To cite this article

V. Granata, R. Fusco, S. Venanzio Setola, C. Sassaroli, S. De Franciscis, P. Delrio, G. Danti, G. Grazzini, L. Faggioni, M. Gabelloni, A. Ottaiano, S. Greggi, R. Patrone, R. Palaia, A. Petrillo, F. Izzo
Radiological assessment of peritoneal carcinomatosis: a primer for resident

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 8
Pages: 2875-2890
DOI: 10.26355/eurrev_202204_28619